- Report
- July 2024
- 115 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- July 2024
- 133 Pages
Global
From €2838EUR$2,990USD£2,394GBP
- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 196 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 197 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- August 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- May 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- October 2024
- 188 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 193 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 283 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 93 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 196 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 492 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 196 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 189 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 250 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2024
- 135 Pages
Global
From €2847EUR$2,999USD£2,402GBP

The Drug Eluting market is a subset of the Medical Devices industry. It is focused on the development and production of drug-eluting devices, which are used to deliver drugs to specific areas of the body. These devices are designed to provide a controlled and sustained release of drugs over a period of time, allowing for more effective treatment of a variety of medical conditions. Drug-eluting devices are used in a variety of medical applications, including cardiovascular, orthopedic, and oncology treatments.
The Drug Eluting market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Medtronic, Abbott, Boston Scientific, Johnson & Johnson, and Stryker. Show Less Read more